Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.
about
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisHerbal medicines for fatty liver diseasesHerbal medicines for fatty liver diseasesBariatric surgery for non-alcoholic steatohepatitis in obese patientsBile acids for non-alcoholic fatty liver disease and/or steatohepatitisDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisTreatment of non-alcoholic fatty liver diseaseLifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsTreatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight LossRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseAdvances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumAging and liver diseaseMagnetic resonance elastography of liver: technique, analysis, and clinical applications.Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?The Effect of Bariatric Surgery on the Spectrum of Fatty Liver DiseasePrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesMagnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss ProgramMetabolic syndrome after liver transplantation: preventable illness or common consequence?Liver fibrosisAutomated liver elasticity calculation for MR elastographyRapid acquisition technique for MR elastography of the liver.Ultrasound in chronic liver disease.Automated liver stiffness measurements with magnetic resonance elastography.Magnetic resonance elastography of liver: clinical applications.Liver failure in an obese middle-aged woman after biliointestinal bypass.Review of MR elastography applications and recent developments.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Current status of novel antifibrotic therapies in patients with chronic liver diseaseCirrhosis and its complications: evidence based treatment.Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver diseaseEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinEffect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver diseaseRegression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research networkLiquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
P2860
Q24197984-F0877BFE-CAEA-4D22-9F05-91DBF56E0060Q24200256-56B28D66-3C8A-4281-BEEE-1A84158EDFB9Q24236298-0FE1A821-401E-4A20-81B2-EF3E70A50A55Q24240455-9246791A-1D52-45E8-8199-D3895F211CF5Q24243149-B2E21D8E-47D4-46CF-BF0A-926152A684D1Q24246447-12F1B0F9-9CC1-4C87-81BD-F29D220E460AQ24655572-3F669F46-51BD-471D-842B-FA51B3B59D38Q26748608-219944A8-4B9E-4C39-8B94-9B422940B8D3Q26772302-49BAA275-A11A-41E7-9D0F-7A0BD93D8832Q26775632-6DD63601-BAA6-4B87-94A7-1340400FC75AQ26778020-94151230-1209-4194-994C-63EDD8D20741Q26784022-B04A24C5-78B9-4431-9570-5AD786B18B40Q26852595-A5C6F7ED-C684-4CF8-8A6E-6CCC9938974DQ27027849-653D52AF-85CA-47B8-9D0A-ED6FBA6BAA34Q27330629-A3B9E64D-E23E-4DCE-9A32-0B8F3D8CA842Q28079820-4ADE8999-F192-4F95-A15C-F2B9F53423E0Q28272678-F65C502D-C59A-4CFC-A216-65C9C4DD9663Q28551574-6A98EB9E-41E0-401D-AF77-0919849B634BQ28728729-7932BA1B-CB54-4AF6-ACCB-ECE165B62649Q29547449-4F8D484D-831A-4C73-BAA8-8BB00383304DQ30357722-6D501EA7-0501-4631-865E-7E47002B66BFQ30430184-19FFA625-BAFA-4785-B778-D9AECD29C36DQ30432218-92022021-C802-4593-A8EA-7CB57323CAC2Q30433801-4786D610-8DDC-42C5-88B0-E40823717CFAQ30435917-188F4C16-FE64-4B8C-BFDD-6A0CD42905D4Q30446406-3565A056-0142-4DB5-9D33-7CD607286A42Q30448711-0DBDB204-F0B5-47F4-BAC7-44BE19E4BC6DQ30467234-5F9BA46D-50F0-4BD8-BA4C-5DBC29476FF0Q30473375-A9C14E1E-8A92-459A-A3D5-FBE68A8F3DF7Q33594931-23781264-5EBD-4DE7-8337-C3EBB3E92B01Q33599564-5CEAF720-9152-4DAA-9E34-930236076F19Q33755829-CAB0E8C8-D097-4F13-A698-1279DD342321Q33776388-86FBA662-6BD3-4FE0-9D65-97763594123AQ33877800-296E0E11-CFA3-45AC-BB50-856878FF607CQ33909796-EA170DF4-EE26-4F5C-A05E-8EE37155A8C5Q33920996-EE0C50D3-3129-403D-B99A-61495BB371DAQ33990270-BEB9B7E0-A88A-4A01-AFF2-A0394AB33443Q34083600-A2FEF23E-17B6-4BBC-8107-813E177CDF81Q34085058-77E60F1C-2F5E-40B0-9A2D-A1510C0C34ACQ34103693-8F9FC8EC-6197-47CE-9906-BD111137B298
P2860
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@en
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@nl
type
label
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@en
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@nl
prefLabel
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@en
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@nl
P2093
P356
P1433
P1476
Nonalcoholic fatty liver disea ...... cal analysis with weight loss.
@en
P2093
John B Dixon
Norman R Hughes
Paul E O'Brien
Prithi S Bhathal
P2860
P304
P356
10.1002/HEP.20251
P407
P577
2004-06-01T00:00:00Z